| Product Code: ETC13321917 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Hospital Acquired Disease Testing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Hospital Acquired Disease Testing Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Hospital Acquired Disease Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Hospital Acquired Disease Testing Market - Industry Life Cycle |
3.4 Europe Hospital Acquired Disease Testing Market - Porter's Five Forces |
3.5 Europe Hospital Acquired Disease Testing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Hospital Acquired Disease Testing Market Revenues & Volume Share, By Infection Type, 2021 & 2031F |
3.7 Europe Hospital Acquired Disease Testing Market Revenues & Volume Share, By Testing Technology, 2021 & 2031F |
3.8 Europe Hospital Acquired Disease Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Europe Hospital Acquired Disease Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Europe Hospital Acquired Disease Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Hospital Acquired Disease Testing Market Trends |
6 Europe Hospital Acquired Disease Testing Market, 2021 - 2031 |
6.1 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Urinary Tract Infections, 2021 - 2031 |
6.1.3 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Surgical Site Infections, 2021 - 2031 |
6.1.4 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Ventilator-associated Pneumonia, 2021 - 2031 |
6.1.5 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Bloodstream Infections, 2020 - 2028 |
6.2 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By PCR-based Diagnostics, 2021 - 2031 |
6.2.3 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Rapid Immunoassays, 2021 - 2031 |
6.2.4 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Culture-based Methods, 2021 - 2031 |
6.2.5 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Molecular Diagnostics, 2021 - 2031 |
6.3 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Healthcare Providers, 2021 - 2031 |
6.3.3 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Hospitals and Clinics, 2021 - 2031 |
6.3.4 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Intensive Care Units, 2021 - 2031 |
6.3.5 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Pathology Laboratories, 2021 - 2031 |
6.4 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Nosocomial Infection Detection, 2021 - 2031 |
6.4.3 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Postoperative Care, 2021 - 2031 |
6.4.4 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Respiratory Infection Screening, 2020 - 2028 |
6.4.5 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Sepsis and Bacteremia Detection, 2020 - 2028 |
7 Europe Hospital Acquired Disease Testing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Hospital Acquired Disease Testing Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
7.2.2 Germany Hospital Acquired Disease Testing Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
7.2.3 France Hospital Acquired Disease Testing Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
7.2.4 Poland Hospital Acquired Disease Testing Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
7.2.5 Spain Hospital Acquired Disease Testing Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
7.2.6 Rest of Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
7.3 Europe Hospital Acquired Disease Testing Market Revenues & Volume Share, By Testing Technology, 2021 & 2031F |
7.3.1 United Kingdom (UK) Hospital Acquired Disease Testing Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
7.3.2 Germany Hospital Acquired Disease Testing Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
7.3.3 France Hospital Acquired Disease Testing Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
7.3.4 Poland Hospital Acquired Disease Testing Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
7.3.5 Spain Hospital Acquired Disease Testing Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
7.3.6 Rest of Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Testing Technology, 2021 - 2031 |
7.4 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United Kingdom (UK) Hospital Acquired Disease Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Germany Hospital Acquired Disease Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 France Hospital Acquired Disease Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.4 Poland Hospital Acquired Disease Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.5 Spain Hospital Acquired Disease Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.6 Rest of Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.1 United Kingdom (UK) Hospital Acquired Disease Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.2 Germany Hospital Acquired Disease Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.3 France Hospital Acquired Disease Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.4 Poland Hospital Acquired Disease Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.5 Spain Hospital Acquired Disease Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.6 Rest of Europe Hospital Acquired Disease Testing Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Europe Hospital Acquired Disease Testing Market Key Performance Indicators |
9 Europe Hospital Acquired Disease Testing Market - Export/Import By Countries Assessment |
10 Europe Hospital Acquired Disease Testing Market - Opportunity Assessment |
10.1 Europe Hospital Acquired Disease Testing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Hospital Acquired Disease Testing Market Opportunity Assessment, By Infection Type, 2021 & 2031F |
10.3 Europe Hospital Acquired Disease Testing Market Opportunity Assessment, By Testing Technology, 2021 & 2031F |
10.4 Europe Hospital Acquired Disease Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 Europe Hospital Acquired Disease Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
11 Europe Hospital Acquired Disease Testing Market - Competitive Landscape |
11.1 Europe Hospital Acquired Disease Testing Market Revenue Share, By Companies, 2022 |
11.2 Europe Hospital Acquired Disease Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here